Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Production of Induced Pluripotent Stem Cell Derived Retinal Pigment Epithelial Cells Fulfilling Regulatory Requirements for Human Transplantation in Dry Age-related Macular Degeneration

NCT02464956 is registered in ClinicalTrials.gov with Moorfields Eye Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02464956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Production of Induced Pluripotent Stem Cell Derived Retinal Pigment Epithelial Cells Fulfilling Regulatory Requirements for Human Transplantation in Dry Age-related Macular Degeneration
Lead sponsor
Moorfields Eye Hospital NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
December 31, 2015
Completion date
February 28, 2019
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration (amd)